Skip to content

XOMA Corporation XOMA Shares (Basic)

Shares (Basic) at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
19.9M+3.6%
Royalty Pharma logo
Royalty PharmaRPRX
436.8M+0.3%
Theravance Biopharma logo
Theravance BiopharmaTBPH
51.3M+3.2%
Innoviva, Inc. logo
Innoviva, Inc.INVA
74.2M+18.3%
Zymeworks logo
ZymeworksZYME
74.7M-0.7%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
100.6M+4.5%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's shares (basic)?
XOMA Corporation (XOMA) reported shares (basic) of 11.9M in Q1 2026.
How has XOMA Corporation's shares (basic) changed year-over-year?
XOMA Corporation's shares (basic) decreased by 0.6% year-over-year, from 12M to 11.9M.
What is the long-term trend for XOMA Corporation's shares (basic)?
Over 4 years (2021 to 2025), XOMA Corporation's shares (basic) has grown at a 1.7% compound annual growth rate (CAGR), from 45.1M to 48.2M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.